Beijing Wehand-bio Pharmaceutical Co., Ltd
Clinical trials sponsored by Beijing Wehand-bio Pharmaceutical Co., Ltd, explained in plain language.
-
New breast cancer drug shows promise in early trial
Disease control CompletedThis early-phase study tested a new chemotherapy drug called WH002 against the standard drug paclitaxel in 40 women with HER2-negative breast cancer. Both drugs were given before surgery, followed by two other chemotherapy drugs. The main goal was to check safety and side effects…
Phase: PHASE1 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Mulberry extract put to the test in early human safety trial
Knowledge-focused CompletedThis early-stage study tested a tablet made from mulberry twig alkaloids (WH006) in 62 healthy and overweight/obese adults in China. The main goal was to check the drug's safety and how it moves through the body, not to treat obesity. Results will help decide if further studies a…
Phase: PHASE1 • Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC